Odds of reversion · patients with supraventricular tachycardia
1 finding from 1 review
no estimate extracted
622 participants
Moderate
Major adverse event: hypotension · patients with supraventricular tachycardia
1 finding from 1 review
no estimate extracted
306 participants
Low
Length of hospital stay · patients with supraventricular tachycardia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient satisfaction · patients with supraventricular tachycardia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality (ticlopidine vs placebo) · patients with type 2 diabetes mellitus
The intervention showed no clear difference in all‐cause mortality (ticlopidine vs placebo) (moderate certainty).
1 finding from 1 review
Intervention not reported
Vascular mortality (ticlopidine vs placebo) · patients with type 2 diabetes mellitus
The intervention showed no clear difference in vascular mortality (ticlopidine vs placebo) (moderate certainty).
1 finding from 1 review
Intervention not reported
Myocardial infarction (fatal and non‐fatal) (ticlopidine vs placebo) · patients with type 2 diabetes mellitus
The intervention showed no clear difference in myocardial infarction (fatal and non‐fatal) (ticlopidine vs placebo) (moderate certainty).
1 finding from 1 review
Intervention not reported
Stroke (fatal and non‐fatal) (a. ticlopidine vs aspirin) (b. clopidogrel vs aspirin & dipyramidole) · patients with type 2 diabetes mellitus
The intervention probably leads to lower stroke (fatal and non‐fatal) (a. ticlopidine vs aspirin) (b.… (moderate certainty).
1 finding from 1 review
Intervention not reported
Health‐related quality of life · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse effects · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Costs · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found